COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Salg i Q3 2017

02/10/2017 - 08:30

Oslo, oktober 2, 2017 - Solon Eiendom solgte 23 boliger med en samlet verdi på 185 millioner kroner i tredje kvartal i år sammenlignet med 38 boliger med en samlet verdi på 230 millioner kroner i tredje kvartal i fjor. [...]

Solon Eiendom ASA : Sales in Q3 2017

02/10/2017 - 08:30

Oslo, October 2, 2017 - Solon Eiendom sold 23 homes with a total sales value of NOK 185 million during the third quarter of 2017 compared to 38 homes with a total sales value of NOK 230 million in the third quarter of [...]

Verona Pharma plc : Total voting rights

02/10/2017 - 08:00

October 2, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), in conformity with DTR 5.6 of the FCA's Disclosure and Transparency Rules, notifies the market that as at 30 September 2017, the [...]

ESPERITE N.V. (ESP) publishes its half-year report. Revenues and results were unexpectedly impacted by pending legal actions.

02/10/2017 - 07:17

CEO , Frédéric Amar will convert 1.5 million shares and will subscribe to 1 million new shares to support the business. Zutphen, The Netherlands - 2 October 2017 Esperite NV (Euronext: ESP, "Esperite" or "the Group") [...]

Alcon introduces new innovations in cataract surgery at European Society of Cataract & Refractive Surgeons 2017 annual congress

02/10/2017 - 07:15

Clareon ® intraocular lens (IOL) implanted with a unique single-use automated pre-loaded delivery system debuts with new data presentations Congress program highlights Alcon's 70-year legacy of innovation including 100 [...]

TiGenix to host Analyst and Investor Event in New York City

02/10/2017 - 07:00

PRESS RELEASE TiGenix to host Analyst and Investor Event in New York City Leuven (BELGIUM) - October 2, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on [...]

TiGenix organisera une réunion d'analystes et d'investisseurs à New York

02/10/2017 - 07:00

COMMUNIQUÉ DE PRESSE TiGenix organisera une réunion d'analystes et d'investisseurs à New York Louvain (BELGIQUE) - 2 octobre 2017, 07h. CET - TiGenix NV (Euronext Brussels et NASDAQ : TIG), société biopharmaceutique de [...]

ABLYNX ANNOUNCES POSITIVE TOPLINE RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP

02/10/2017 - 07:00

REGULATED INFORMATION - INSIDE INFORMATION Caplacizumab meets primary endpoint and key secondary endpoints Statistically significant reduction in time to platelet count response, with at any given time patients treated [...]

ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting

29/09/2017 - 21:16

Zutphen, The Netherlands - 29 September 2017 Esperite N.V. (Euronext: ESP, the " Company " or " Esperite ") announces that the Company expects to publish its Interim Financial Reporting on or before 2 October 2017. [...]

Summit Therapeutics plc : Exercise of Share Options

29/09/2017 - 19:20

Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 29 September 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing [...]

MEDASYS : Chiffre d'affaires et résultats consolidés du 1er semestre 2017

29/09/2017 - 19:15

Clamart, le 29 septembre 2017 - Medasys, principal éditeur et intégrateur français de logiciels médicaux pour établissements de santé, publics et privés, dans les domaines du dossier patient, de la production de soins [...]

GUERBET : Mise à disposition du Rapport Financier semestriel 2017

29/09/2017 - 18:03

Villepinte, le 29 septembre 2017 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, annonce ce jour avoir mis à la disposition du public et déposé auprès [...]

Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

29/09/2017 - 17:27

TORONTO, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (" Khiron " or the " Company ") reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration ("DEA") Chief of [...]

Novo Nordisk's new fast-acting mealtime insulin Fiasp® approved in the US

29/09/2017 - 16:10

Bagsværd, Denmark, 29 September 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Fiasp ® (fast-acting insulin aspart), a new fast-acting mealtime insulin, for the treatment [...]

CHMP endorses Tresiba® label update in the EU - new label reflects significant reduction in the risk of severe hypoglycaemia

29/09/2017 - 15:52

Bagsværd, Denmark, 29 September 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has endorsed an update of the EU label with [...]

Ambu A/S: Financial Diary

29/09/2017 - 13:05

Financial Diary 2017/18 31 October 2017: Deadline for the inclusion of specific items on the agenda of the annual general meeting 2016/17 9 November 2017: Annual Report 2016/17 (Earnings release) 13 December 2017: [...]

Total number of shares and voting rights in Zealand at September 30, 2017

29/09/2017 - 10:49

Company announcement - No. 47 / 2017 Total number of shares and voting rights in Zealand at September 30, 2017 Copenhagen, September 29, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' [...]

To Enable Better Targeting Of Resources, Skåne University Hospital Starts To Use New Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease (CAD)

29/09/2017 - 09:00

Press release Malmö, September 29, 2017 On World Heart Day Latest Data Shows Heart Disease Remains Most Common Cause of Death in Sweden To Enable Better Targeting Of Resources, Skåne University Hospital Starts To Use [...]

Solon Eiendom ASA : Primary insider notification

29/09/2017 - 08:30

(Oslo, Norway, 28 September 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 10,000 shares in Solon Eiendom ASA at a price of NOK 18.3839 per [...]